Find us on...
On 24 October 2024, the Office for Product Safety and Standards (OPSS) issued a call for data on the safety of a number of cosmetic ingredients for their review. The ingredients of interest are listed below.
- Prostaglandins and prostaglandin analogues: due to their potency, intended use in the proximity of the eye and concerns raised by other scientific bodies and regulators over their safety.
- Isopropyl closprostenate (CAS 157283-66-4)
- Bimatoprost (CAS 155206-00-1)
- Ethyl tafluprostamide (CAS 209860-87-7)
- Norbimatoprost
- Methylamido dihydro noralfaprostal
- Alpha and beta arbutin: OPSS has concerns regarding the risks associated with the use of these ingredients in cosmetic products due to their degradation to hydroquinone under common storage conditions.
- Vitamin A: there is a potential risk to human health arising from the use of vitamin A in cosmetic products when its concentration exceeds certain levels.
The deadline for submission is 30 April 2025.
For any further information on the call for data, please contact OPSS at [email protected].
